Aerovate Therapeutics Inc (AVTE)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: AVTE Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-04-19 2024-04-17 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
1,000 -8.7%
23.33
100,000 USD 		1,000 -8.7% 23.33 100,000 USD
2024-04-19 2024-04-17 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
1,000 -50.9%
22.30
100,000 USD 		1,000 -50.9% 22.30 100,000 USD
2024-04-19 2024-04-17 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
1,000 -5.0%
23.97
100,000 USD 		1,000 -5.0% 23.97 100,000 USD
2024-04-19 2024-04-17 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
1,000 -19.9%
23.17
100,000 USD 		1,000 -19.9% 23.17 100,000 USD
2024-04-19 2024-04-17 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
1,000 -79.2%
22.32
100,000 USD 		1,000 -79.2% 22.32 100,000 USD
2024-04-18 2024-04-16 PS Planned sale

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
5,509 -100.0%
24.94
137,410 USD 		5,509 -100.0% 24.94 137,410 USD
2024-04-18 2024-04-16 PS Planned sale

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
4,491 -44.9%
24.40
109,561 USD 		4,491 -44.9% 24.40 109,561 USD
2024-04-12 2024-04-10 PS Planned sale

Eldridge George A

SEE REMARKS

Officer
771 -28.2%
27.56
21,252 USD 		771 -28.2% 27.56 21,252 USD
2024-04-12 2024-04-10 PS Planned sale

Eldridge George A

SEE REMARKS

Officer
6,729 -71.1%
26.77
180,139 USD 		6,729 -71.1% 26.77 180,139 USD
2024-04-11 2024-04-09 S Sale

GRAYZEL DAVID S.

Non-Executive Director
11,882 -45.0%
28.15
334,478 USD 		11,882 -45.0% 28.15 334,478 USD
2024-04-03 2024-04-01 PS Planned sale

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
1,000 -100.0%
31.95
31,950 USD 		1,000 -100.0% 31.95 31,950 USD
2024-04-03 2024-04-01 PS Planned sale

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
2,851 -74.0%
31.02
88,446 USD 		2,851 -74.0% 31.02 88,446 USD
2024-04-03 2024-04-01 PS Planned sale

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
1,647 -30.0%
29.90
49,238 USD 		1,647 -30.0% 29.90 49,238 USD
2024-04-03 2024-04-01 PS Planned sale

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
4,502 -45.0%
28.96
130,399 USD 		4,502 -45.0% 28.96 130,399 USD
2024-04-03 2024-04-01 PS Planned sale

Verwijs Marinus

CHIEF TECHNICAL OFFICER

Officer
1,504 -100.0%
30.00
45,118 USD 		1,504 -100.0% 30.00 45,118 USD
2024-04-03 2024-04-01 PS Planned sale

Verwijs Marinus

CHIEF TECHNICAL OFFICER

Officer
3,796 -71.6%
28.87
109,579 USD 		3,796 -71.6% 28.87 109,579 USD
2024-04-03 2024-04-01 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
3,325 -72.0%
31.97
106,317 USD 		3,325 -72.0% 31.97 106,317 USD
2024-04-03 2024-04-01 PS Planned sale

Eldridge George A

SEE REMARKS

Officer
12,495 -86.4%
31.23
390,208 USD 		12,495 -86.4% 31.23 390,208 USD
2024-04-01 2024-03-28 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
9,000 -73.5%
29.50
265,500 USD 		9,000 -73.5% 29.50 265,500 USD
2024-03-28 2024-03-27 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
11,068 -89.6%
27.97
309,519 USD 		11,068 -89.6% 27.97 309,519 USD
2024-03-27 2024-03-25 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
3,432 -72.7%
28.01
96,119 USD 		3,432 -72.7% 28.01 96,119 USD
2024-03-20 2024-03-19 PS Planned sale

Verwijs Marinus

CHIEF TECHNICAL OFFICER

Officer
2,764 -100.0%
26.46
73,124 USD 		2,764 -100.0% 26.46 73,124 USD
2024-03-20 2024-03-19 PS Planned sale

Verwijs Marinus

CHIEF TECHNICAL OFFICER

Officer
2,536 -47.8%
25.68
65,119 USD 		2,536 -47.8% 25.68 65,119 USD
2024-03-20 2024-03-18 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
7,581 -85.4%
26.48
200,764 USD 		7,581 -85.4% 26.48 200,764 USD
2024-03-20 2024-03-18 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
27,476 -75.6%
25.74
707,282 USD 		27,476 -75.6% 25.74 707,282 USD
2024-03-20 2024-03-18 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
613 -15.9%
26.40
16,185 USD 		613 -15.9% 26.40 16,185 USD
2024-03-20 2024-03-18 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
6,387 -62.3%
25.81
164,872 USD 		6,387 -62.3% 25.81 164,872 USD
2024-03-14 2024-03-13 PS Planned sale

Eldridge George A

SEE REMARKS

Officer
2,016 -50.7%
25.02
50,445 USD 		2,016 -50.7% 25.02 50,445 USD
2024-03-14 2024-03-12 PS Planned sale

Eldridge George A

SEE REMARKS

Officer
2,051 -51.1%
25.05
51,370 USD 		2,051 -51.1% 25.05 51,370 USD
2024-03-11 2024-03-11 PS Planned sale

Eldridge George A

SEE REMARKS

Officer
10 -0.5%
26.31
263 USD 		10 -0.5% 26.31 263 USD
2024-03-11 2024-03-11 PS Planned sale

Eldridge George A

SEE REMARKS

Officer
3,423 -63.5%
25.24
86,404 USD 		3,423 -63.5% 25.24 86,404 USD
2024-03-11 2024-03-08 PS Planned sale

Eldridge George A

SEE REMARKS

Officer
114 -5.5%
25.00
2,850 USD 		114 -5.5% 25.00 2,850 USD
2024-03-11 2024-03-07 PS Planned sale

Eldridge George A

SEE REMARKS

Officer
22,386 -91.9%
25.00
559,688 USD 		22,386 -91.9% 25.00 559,688 USD
2024-03-11 2024-03-07 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
8,975 -73.4%
24.50
219,888 USD 		8,975 -73.4% 24.50 219,888 USD
2024-02-27 2024-02-23 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
511 -13.6%
19.50
9,965 USD 		511 -13.6% 19.50 9,965 USD
2024-02-22 2024-02-20 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
898 -21.6%
20.58
18,478 USD 		898 -21.6% 20.58 18,478 USD
2024-02-22 2024-02-20 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
2,591 -38.4%
20.11
52,097 USD 		2,591 -38.4% 20.11 52,097 USD
2024-02-07 2024-02-05 PS Planned sale

NIVEN RALPH

CHIEF SCIENTIFIC OFFICER

Officer
4,600 -74.1%
17.45
80,249 USD 		4,600 -74.1% 17.45 80,249 USD
2024-01-19 2024-01-17 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
4,000 -55.2%
19.50
78,000 USD 		4,000 -55.2% 19.50 78,000 USD
2024-01-08 2024-01-05 PS Planned sale

NIVEN RALPH

CHIEF SCIENTIFIC OFFICER

Officer
2,474 -60.6%
19.57
48,421 USD 		2,474 -60.6% 19.57 48,421 USD
2024-01-08 2024-01-05 PS Planned sale

NIVEN RALPH

CHIEF SCIENTIFIC OFFICER

Officer
2,126 -34.2%
18.67
39,695 USD 		2,126 -34.2% 18.67 39,695 USD
2023-12-29 2023-12-27 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
125 -3.7%
24.50
3,063 USD 		125 -3.7% 24.50 3,063 USD
2023-12-22 2023-12-20 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
4,000 -55.2%
19.50
78,000 USD 		4,000 -55.2% 19.50 78,000 USD
2023-12-15 2023-12-14 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
9,897 -75.3%
19.50
192,992 USD 		9,897 -75.3% 19.50 192,992 USD
2023-12-15 2023-12-13 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
2,103 -39.3%
19.50
41,009 USD 		2,103 -39.3% 19.50 41,009 USD
2023-12-07 2023-12-06 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
10,283 -88.8%
16.11
165,628 USD 		10,283 -88.8% 16.11 165,628 USD
2023-12-07 2023-12-05 PS Planned sale

NIVEN RALPH

CHIEF SCIENTIFIC OFFICER

Officer
4,600 -74.1%
16.30
74,996 USD 		4,600 -74.1% 16.30 74,996 USD
2023-11-29 2023-11-27 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
12,517 -90.7%
16.24
203,237 USD 		12,517 -90.7% 16.24 203,237 USD
2023-11-27 2023-11-24 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
70 -5.1%
16.07
1,125 USD 		70 -5.1% 16.07 1,125 USD
2023-11-27 2023-11-24 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
4,920 -78.3%
15.74
77,423 USD 		4,920 -78.3% 15.74 77,423 USD
2023-11-27 2023-11-22 PS Planned sale

NIVEN RALPH

CHIEF SCIENTIFIC OFFICER

Officer
13,800 -89.6%
15.00
207,000 USD 		13,800 -89.6% 15.00 207,000 USD
2023-11-27 2023-11-22 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
9,382 -87.9%
15.17
142,359 USD 		9,382 -87.9% 15.17 142,359 USD
2023-11-03 2023-11-01 PS Planned sale

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
1,092 -100.0%
10.42
11,379 USD 		1,092 -100.0% 10.42 11,379 USD
2023-11-03 2023-11-01 PS Planned sale

Verwijs Marinus

CHIEF TECHNOLOGY OFFICER

Officer
970 -100.0%
10.46
10,149 USD 		970 -100.0% 10.46 10,149 USD
2023-09-08 2023-09-07 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
30 -2.3%
15.01
450 USD 		30 -2.3% 15.01 450 USD
2023-09-08 2023-09-06 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
3,931 -75.3%
15.06
59,187 USD 		3,931 -75.3% 15.06 59,187 USD
2023-08-09 2023-08-07 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
541 -29.5%
16.25
8,789 USD 		541 -29.5% 16.25 8,789 USD
2023-08-09 2023-08-07 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
9,742 -84.2%
15.48
150,792 USD 		9,742 -84.2% 15.48 150,792 USD
2023-08-01 2023-07-28 PS Planned sale

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
5,478 -100.0%
18.00
98,604 USD 		5,478 -100.0% 18.00 98,604 USD
2023-07-19 2023-07-17 PS Planned sale

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
4,522 -100.0%
18.11
81,896 USD 		4,522 -100.0% 18.11 81,896 USD
2023-07-07 2023-07-06 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
10,283 -88.8%
16.66
171,284 USD 		10,283 -88.8% 16.66 171,284 USD
2023-07-07 2023-07-05 PS Planned sale

NIVEN RALPH

CHIEF SCIENTIFIC OFFICER

Officer
219 -12.0%
17.87
3,913 USD 		219 -12.0% 17.87 3,913 USD
2023-07-07 2023-07-05 PS Planned sale

NIVEN RALPH

CHIEF SCIENTIFIC OFFICER

Officer
2,031 -52.6%
17.23
35,002 USD 		2,031 -52.6% 17.23 35,002 USD
2023-07-05 2023-07-03 PS Planned sale

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
10,000 -100.0%
18.00
180,000 USD 		10,000 -100.0% 18.00 180,000 USD
2023-06-08 2023-06-06 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
15 -1.1%
16.98
255 USD 		15 -1.1% 16.98 255 USD
2023-06-08 2023-06-06 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
10,268 -88.7%
16.28
167,161 USD 		10,268 -88.7% 16.28 167,161 USD
2023-06-07 2023-06-05 PS Planned sale

NIVEN RALPH

CHIEF SCIENTIFIC OFFICER

Officer
2,250 -58.3%
16.26
36,576 USD 		2,250 -58.3% 16.26 36,576 USD
2023-05-23 2023-05-19 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
65 -2.0%
19.50
1,268 USD 		65 -2.0% 19.50 1,268 USD
2023-05-19 2023-05-17 PS Planned sale

Gillies Hunter

CHIEF MEDICAL OFFICER

Officer
1,090 -25.1%
19.59
21,356 USD 		1,090 -25.1% 19.59 21,356 USD
2023-05-09 2023-05-08 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
1,599 -55.3%
22.74
36,355 USD 		1,599 -55.3% 22.74 36,355 USD
2023-05-09 2023-05-08 PS Planned sale

Dake Benjamin T

SEE REMARKS

Officer
8,685 -75.0%
21.62
187,805 USD 		8,685 -75.0% 21.62 187,805 USD
2023-05-09 2023-05-05 PS Planned sale

NIVEN RALPH

CHIEF SCIENTIFIC OFFICER

Officer
205 -11.3%
21.63
4,435 USD 		205 -11.3% 21.63 4,435 USD
2023-05-09 2023-05-05 PS Planned sale

NIVEN RALPH

CHIEF SCIENTIFIC OFFICER

Officer
2,045 -53.0%
20.79
42,522 USD 		2,045 -53.0% 20.79 42,522 USD
2023-05-05 2023-05-03 PS Planned sale

Verwijs Marinus

SENIOR VICE PRESIDENT, CMC

Officer
759 -100.0%
20.79
15,779 USD 		759 -100.0% 20.79 15,779 USD
2023-05-03 2023-05-02 PS Planned sale

NOYES TIMOTHY P

CHIEF EXECUTIVE OFFICER

Executive Director
693 -100.0%
21.15
14,657 USD 		693 -100.0% 21.15 14,657 USD